Malignant pleural mesothelioma-the impact of globalization on rare diseases.
作者信息
Hoda M Alireza, Ploenes Till, Aigner Clemens
机构信息
Mesothelioma Program, Department of Thoracic Surgery and Thoracic Endoscopy, University Medicine Essen-Ruhrlandklinik, Essen, Germany.
出版信息
J Thorac Dis. 2018 Feb;10(2):638-640. doi: 10.21037/jtd.2017.12.139.
Abstract
摘要
相似文献
1
Malignant pleural mesothelioma-the impact of globalization on rare diseases.恶性胸膜间皮瘤——全球化对罕见病的影响。
J Thorac Dis. 2018 Feb;10(2):638-640. doi: 10.21037/jtd.2017.12.139.
2
[Malignant pleural mesothelioma with an unusual radiologic manifestation].[具有不寻常放射学表现的恶性胸膜间皮瘤]
An Med Interna. 1999 Jul;16(7):354-6.
3
Detection of integrin-linked kinase in the serum of patients with malignant pleural mesothelioma.检测恶性胸膜间皮瘤患者血清中的整合素连接激酶。
J Thorac Cardiovasc Surg. 2011 Aug;142(2):384-9. doi: 10.1016/j.jtcvs.2011.04.034. Epub 2011 May 26.
4
Membranous glomerulonephritis associated with diffuse malignant pleural mesothelioma: report of a case.膜性肾小球肾炎合并弥漫性恶性胸膜间皮瘤：一例报告
Surg Today. 2000;30(12):1124-6. doi: 10.1007/s005950070014.
5
Malignant Mesothelioma Versus Metastatic Carcinoma of the Pleura: A CT Challenge.恶性间皮瘤与胸膜转移性癌：CT诊断难题
Iran J Radiol. 2016 Jan 14;13(1):e10949. doi: 10.5812/iranjradiol.10949. eCollection 2016 Jan.
6
Localized malignant pleural mesothelioma: report of two cases.局限性恶性胸膜间皮瘤：2例报告
J Thorac Oncol. 2009 Aug;4(8):1038-40. doi: 10.1097/JTO.0b013e3181a8c874.
7
Utility of hyaluronic acid in pleural fluid for differential diagnosis of pleural effusions: likelihood ratios for malignant mesothelioma.透明质酸在胸腔积液中对胸腔积液鉴别诊断的效用：恶性间皮瘤的似然比
Jpn J Clin Oncol. 1997 Oct;27(5):293-7. doi: 10.1093/jjco/27.5.293.
8
[Computed tomographic findings in diffuse malignant pleural mesothelioma].[弥漫性恶性胸膜间皮瘤的计算机断层扫描表现]
Rofo. 1985 Sep;143(3):279-84. doi: 10.1055/s-2008-1052808.
9
Malignant pleural mesothelioma initially diagnosed on cervical lymph node biopsy.最初通过颈部淋巴结活检诊断出的恶性胸膜间皮瘤。
Pathol Int. 2009 Aug;59(8):592-4. doi: 10.1111/j.1440-1827.2009.02412.x.
10
[A case of triple malignancies (gastric cancer, lung cancer and malignant pleural mesothelioma) after asbestos exposure].一例石棉暴露后发生的三重恶性肿瘤（胃癌、肺癌和恶性胸膜间皮瘤）
Nihon Kokyuki Gakkai Zasshi. 2003 Apr;41(4):304-9.
引用本文的文献
1
Expression of estrogen receptor beta (ERβ) and its prognostic value in pleural mesothelioma.雌激素受体β（ERβ）在胸膜间皮瘤中的表达及其预后价值。
J Thorac Dis. 2019 Apr;11(4):1456-1464. doi: 10.21037/jtd.2019.03.38.
本文引用的文献
1
The IASLC Mesothelioma Staging Project: Proposals for Revisions of the N Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Pleural Mesothelioma.国际肺癌研究协会间皮瘤分期项目：即将发布的第八版胸膜间皮瘤 TNM 分类中 N 描述符修订建议。
J Thorac Oncol. 2016 Dec;11(12):2100-2111. doi: 10.1016/j.jtho.2016.09.121. Epub 2016 Sep 26.
2
The IASLC Mesothelioma Staging Project: Proposals for Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Pleural Mesothelioma.IASLC 间皮瘤分期项目：对即将发布的第八版胸膜间皮瘤 TNM 分类中 T 描述符的修订建议。
J Thorac Oncol. 2016 Dec;11(12):2089-2099. doi: 10.1016/j.jtho.2016.08.147. Epub 2016 Sep 26.
3
The IASLC Mesothelioma Staging Project: Proposals for the M Descriptors and for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Mesothelioma.国际肺癌研究协会间皮瘤分期项目：M 描述符建议和即将发布的（第八版）间皮瘤 TNM 分类中 TNM 分期分组的修订。
J Thorac Oncol. 2016 Dec;11(12):2112-2119. doi: 10.1016/j.jtho.2016.09.124. Epub 2016 Sep 28.
4
The IASLC Mesothelioma Staging Project: Improving Staging of a Rare Disease Through International Participation.IASLC 间皮瘤分期项目：通过国际参与改善罕见病分期。
J Thorac Oncol. 2016 Dec;11(12):2082-2088. doi: 10.1016/j.jtho.2016.09.123. Epub 2016 Sep 23.
5
Supplementary prognostic variables for pleural mesothelioma: a report from the IASLC staging committee.胸膜间皮瘤的补充预后变量：IASLC 分期委员会的报告。
J Thorac Oncol. 2014 Jun;9(6):856-64. doi: 10.1097/JTO.0000000000000181.
6
Initial analysis of the international association for the study of lung cancer mesothelioma database.国际肺癌研究协会间皮瘤数据库的初步分析。
J Thorac Oncol. 2012 Nov;7(11):1631-9. doi: 10.1097/JTO.0b013e31826915f1.
7
Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients.切除边缘、胸膜外淋巴结状态和细胞类型决定恶性胸膜间皮瘤三联疗法的术后长期生存：183例患者的结果
J Thorac Cardiovasc Surg. 1999 Jan;117(1):54-63; discussion 63-5. doi: 10.1016/s0022-5223(99)70469-1.
8
Evaluation of the clinical TNM staging system for malignant pleural mesothelioma: an assessment in 88 patients.恶性胸膜间皮瘤临床TNM分期系统的评估：88例患者的分析
Lung Cancer. 1995 Mar;12(1-2):25-34. doi: 10.1016/0169-5002(94)00404-b.
9
A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group.一种针对恶性胸膜间皮瘤的新提议国际TNM分期系统。来自国际间皮瘤兴趣小组。
Chest. 1995 Oct;108(4):1122-8. doi: 10.1378/chest.108.4.1122.
10
Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients.胸膜全肺切除术治疗弥漫性恶性胸膜间皮瘤。29例患者的经验。
Thorax. 1976 Feb;31(1):15-24. doi: 10.1136/thx.31.1.15.
Zotero 插件